Bajaj HealthCare Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Bajaj HealthCare ha un patrimonio netto totale di ₹4.5B e un debito totale di ₹2.1B, che porta il suo rapporto debito/patrimonio netto a 46%. Le sue attività totali e le sue passività totali sono rispettivamente ₹8.0B e ₹3.6B. L'EBIT di Bajaj HealthCare è ₹566.0M rendendo il suo rapporto di copertura degli interessi 2. Ha liquidità e investimenti a breve termine pari a ₹228.4M.

Informazioni chiave

46.0%

Rapporto debito/patrimonio netto

₹2.05b

Debito

Indice di copertura degli interessi	2x
Contanti	₹228.40m
Patrimonio netto	₹4.46b
Totale passività	₹3.58b
Totale attività	₹8.04b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Bajaj HealthCare's (NSE:BAJAJHCARE) Dividend Will Be ₹1.00

Sep 12

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Jul 12

Bajaj HealthCare (NSE:BAJAJHCARE) Has Announced That Its Dividend Will Be Reduced To ₹1.00

Sep 10

We Think That There Are More Issues For Bajaj HealthCare (NSE:BAJAJHCARE) Than Just Sluggish Earnings

Nov 19

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Soars 30% But It's A Story Of Risk Vs Reward

Jan 17

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( ₹5.3B ) di BAJAJHCARE superano le sue passività a breve termine ( ₹3.2B ).

Passività a lungo termine: Le attività a breve termine di BAJAJHCARE ( ₹5.3B ) superano le sue passività a lungo termine ( ₹378.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 40.9% ) di BAJAJHCARE è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di BAJAJHCARE si è ridotto da 55.3% a 46% negli ultimi 5 anni.

Copertura del debito: Il debito di BAJAJHCARE è ben coperto dal flusso di cassa operativo ( 37.3% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di BAJAJHCARE non sono ben coperti dall'EBIT ( 2 x copertura).

Bajaj HealthCare Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

New minor risk - Shareholder dilution

Bajaj HealthCare Limited to Report Q2, 2025 Results on Nov 14, 2024

Now 20% overvalued

Bajaj HealthCare's (NSE:BAJAJHCARE) Dividend Will Be ₹1.00

Dividend of ₹1.00 announced

Bajaj HealthCare Limited, Annual General Meeting, Sep 30, 2024

Bajaj HealthCare Limited, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: EPS: ₹2.92 (vs ₹2.55 in 1Q 2024)

Bajaj Healthcare Limited Appoints Yaqoob Ali as an Additional Non-Executive Independent Director

Bajaj HealthCare Limited to Report Q1, 2025 Results on Aug 14, 2024

New minor risk - Shareholder dilution

Bajaj HealthCare Limited announced that it expects to receive INR 1.542870037 billion in funding from Swastik Capital & Stock Pvt Ltd., Universal Golden Fund, Akshat Greentech Private Limited, Sudha Commercial Company Ltd. and other investors

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Bajaj HealthCare Limited announced that it expects to receive INR 1.542870037 billion in funding from Swastik Capital & Stock Pvt Ltd., Universal Golden Fund, Akshat Greentech Private Limited, Sudha Commercial Company Ltd. and other investors

Full year 2024 earnings released: ₹5.19 loss per share (vs ₹15.59 profit in FY 2023)

New major risk - Revenue and earnings growth

Bajaj Healthcare Limited Recommends Final Dividend for the Financial Year Ended 31St March, 2024

Bajaj HealthCare Limited to Report Q4, 2024 Results on May 24, 2024

New minor risk - Market cap size

Third quarter 2024 earnings released: EPS: ₹2.01 (vs ₹4.01 in 3Q 2023)

Bajaj Healthcare Limited Announces Resignation of Rupesh Nikam as Chief Financial Officer (Cfo)

Bajaj Healthcare Limited Announces Resignation of Avinash K. Dalal as Non-Executive Independent Director

Vice Chairman & Joint MD recently bought ₹4.0m worth of stock

Second quarter 2024 earnings released: EPS: ₹1.85 (vs ₹5.93 in 2Q 2023)

Bajaj Healthcare Limited Approves Appointment of Amit Rajan as Chief Technical Officer

Bajaj Healthcare Limited Approves Appointment of Amit Rajan as Chief Technical Officer

Bajaj HealthCare Limited to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of ₹1.00 per share at 0.2% yield

Bajaj HealthCare (NSE:BAJAJHCARE) Has Announced That Its Dividend Will Be Reduced To ₹1.00

Bajaj HealthCare Limited, Annual General Meeting, Sep 30, 2023

First quarter 2024 earnings released: EPS: ₹2.55 (vs ₹4.35 in 1Q 2023)

Bajaj HealthCare Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings released: EPS: ₹15.59 (vs ₹25.87 in FY 2022)

Bajaj HealthCare Limited to Report Q4, 2023 Results on May 30, 2023

Founder recently bought ₹4.0m worth of stock

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: ₹4.01 (vs ₹6.32 in 3Q 2022)

Bajaj HealthCare Limited to Report Q3, 2023 Results on Feb 13, 2023

Vice Chairman & Joint MD recently bought ₹2.4m worth of stock

Chairman & MD recently bought ₹5.0m worth of stock

US Food and drug administration Conducts its Pre Approval inspection at Bajaj HealthCare Limited's API Facility

We Think That There Are More Issues For Bajaj HealthCare (NSE:BAJAJHCARE) Than Just Sluggish Earnings

Second quarter 2023 earnings released: EPS: ₹5.93 (vs ₹6.25 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹5.93 (vs ₹6.25 in 2Q 2022)

Bajaj HealthCare Limited to Report Q2, 2023 Results on Nov 11, 2022

Bajaj HealthCare Limited, Annual General Meeting, Sep 30, 2022

First quarter 2023 earnings released: EPS: ₹4.35 (vs ₹6.97 in 1Q 2022)

Bajaj HealthCare Limited to Report Q1, 2023 Results on Aug 12, 2022

Bajaj Healthcare Limited Provides Earnings Guidance for the Year 2023

Bajaj Healthcare Limited Recommends Final Dividend for the Financial Year Ended 31 March, 2022

Bajaj HealthCare Limited Announces Operations Reinstated At Panoli Unit

High number of new directors

Investor sentiment improved over the past week

Whole Time Director recently bought ₹1.2m worth of stock

Bajaj HealthCare Limited Launches Magnesium L-Threonate in Nutraceutical Segment

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Soars 30% But It's A Story Of Risk Vs Reward

Investor sentiment improved over the past week

High number of new directors

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane